TCR2 THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Dec 2023)
What this means for you
This application is over — abandoned 11 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97097081
- Mark type
- Word mark
- Filed
- 28 Oct 2021
- Published for opposition
- 13 Sept 2022
- Abandoned
- 11 Dec 2023
- Attorney of record
- Brandon P. Leahy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases
- Class 042 — Scientific and technological services: Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
Owner
- TCR2 Therapeutics Inc., Cambridge, MA, US
- TCR2 Therapeutics Inc., Cambridge, MA, US
Prosecution history
- 11 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2023 — SOU EXTENSION 1 GRANTED
- 04 Apr 2023 — SOU EXTENSION 1 FILED
- 04 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Sept 2022 — PUBLISHED FOR OPPOSITION
- 24 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Aug 2022 — EXAMINER'S AMENDMENT ENTERED
- 10 Aug 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Aug 2022 — EXAMINERS AMENDMENT E-MAILED
- 10 Aug 2022 — EXAMINERS AMENDMENT -WRITTEN